Recently, an immune checkpoint inhibitor, programmed cell death protein-1 (PD-1), and programmed cell death ligand-1 (PD-L1), showed potential for the treatment of advanced cervical cancer [19]. The gene discussed is PDCD1; the disease is cervical cancer.